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Abstract
Background: A global proteomic strategy was used to identify proteins, which are differentially expressed in the
murine model of severe malaria in the hope of facilitating future development of novel diagnostic, disease
monitoring and treatment strategies.
Methods: Mice (4-week-old CD1 male mice) were infected with Plasmodium berghei ANKA strain, and infection
allowed to establish until a parasitaemia of 30% was attained. Total plasma and albumin depleted plasma samples
from infected and control (non-infected) mice were separated by two-dimensional gel electrophoresis (2-DE). After
staining, the gels were imaged and differential protein expression patterns were interrogated using image analysis
software. Spots of interest were then digested using trypsin and the proteins identified using matrix-assisted laser
desorption and ionization-time of flight (MALDI-TOF) mass spectrometry (MS) and peptide mass fingerprinting
software.
Results: Master gels of control and infected mice, and the corresponding albumin depleted fractions exhibited
distinctly different 2D patterns comparing control and infected plasma, respectively. A wide range of proteins
demonstrated altered expression including; acute inflammatory proteins, transporters, binding proteins, protease
inhibitors, enzymes, cytokines, hormones, and channel/receptor-derived proteins.
Conclusions: Malaria-infection in mice results in a wide perturbation of the host serum proteome involving a
range of proteins and functions. Of particular interest is the increased secretion of anti-inflammatory and anti
apoptotic proteins.
Background
Malaria continues to affect millions of people in sub-
Saharan Africa, where severe falciparum malaria is a
major cause of childhood mortality. The malaria parasite
infects 300-500 million people per year, causing over 1
million deaths [1]. In light of this, there is a need to bet-
ter understand the biochemical changes associated with
severe malaria as the definitive cause of death is often
unknown.
Animal models of cerebral malaria have been devel-
oped to provide insight in to the pathogenesis of the
disease although it is accepted that there are differences
from the human condition. Cerebral malaria is induced
in susceptible strains of mice by the ANKA strain of
Plasmodium berghei [2]. These murine models of cere-
bral malaria have been used in the past to throw light
on the pathogenesis of the human condition [3-6].
Proteome analysis is the direct measurement of all
proteins in a system in terms of their presence and
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relative abundance at a specific point in time under
defined conditions. Proteomics is regarded as compli-
mentary technology to genome analysis. Proteins con-
tain several dimensions that collectively indicate the
actual rather than the potential functional state as indi-
cated in mRNA analysis. Although the pattern of gene
activity will be abnormal in a tissue with pathological
lesions, there can be poor correlation between the level
of activity of different genes and the abundance of their
corresponding proteins within tissues [7]. Proteomic stu-
dies characterize the complex network of cell regulation
at the protein level.
Here, the use of a global proteomic strategy to identify
proteins differentially expressed in the murine model of
cerebral malaria is reported. This work was conducted
in order to identify opportunities for the development of
novel diagnostic, disease monitoring techniques, and
possible future treatments.
Methods
Mouse samples
Plasma was collected from 4-week-old CD1 male mice
(n = 3) infected with the ANKA (PbA) strain of P. ber-
ghei originally obtained from the London School of Tro-
pical Medicine and Hygiene (0.1 ml of a culture with 2%
parasitaemia). A control set of plasma was collected
from mice (n = 2) without infection. The samples were
separated into two aliquots and albumin was depleted
from one aliquot using the Montage Albumin kit (Milli-
pore, USA). Proteomic analysis was carried out sepa-
rately on each sample.
The use of mice in these experiments was undertaken
in accordance with criteria outlined in a license granted
under the Animals (Scientific Procedures) Act of 1986
and approved by the University of Liverpool Animal
Ethics Committee.
Two-dimensional electrophoresis (2-DE)
The first separation (first dimension) was carried out on
a Multiphor II flat bed electrophoresis system (Pharma-
cia Biotech, Uppsala, Sweden). Ready-made strips
Immobiline Drystrip gels (IPG) with a pH gradient 3-10
NL (non-linear) 13 cm long (Amersham Pharmacia Bio-
tech, Bucks, UK) were used. The strips were passively
rehydrated overnight at room temperature with a rehy-
dration buffer (8 M Urea, 3% CHAPS, 0.5% IPG buffer
3-10, 10 mM DTT, and a trace amount of bromophenol
blue), which contained 75 μg of plasma protein for pre-
parative gels and 300 μg for analytical gels. Isoelectric
focusing was carried out using multi-step conditions (1
h at 150 V, 1 h at 300 V, 1 h at 1500 V, 18 h at 3000V).
Before the second dimension each strip was equilibrated
by incubating for 15 minutes at room temperature in 10
ml of equilibration buffer (50 mM Tris-HCl, pH 8.8, 6
M urea, 30% w/v glycerol, 2% w/v SDS and a trace of
Bromophenol Blue) with 1% w/v DTT. A second equili-
brating step of 15 minutes was performed in 10 ml
equilibration buffer containing 4%w/v iodoacetamide.
The second dimension was performed on home made
12.5% homogenous vertical SDS-polyacrylamide gel
slabs (gel plate size 180 × 160 mm and a gel thickness
1.5 mm) employing a Laemmli buffer system[8]. Electro-
phoresis was performed at 20°C under a constant cur-
rent of 25 mA per gel using a Hoefer SE 600 series
vertical slab gel electrophoresis unit (Amersham Phar-
macia Biotech, Bucks, UK).
Protein visualization and image analysis
Analytical gels were silver stained using a protocol
described by Blum et al [9] with modifications described
by Rabilloud et al [10]. Preparative gels were stained
using colloidal Coomassie Brilliant Blue G-250 as pre-
viously described by Neuhoff et al [11]. The stained gels
were scanned using a GS-710 Imaging Densitometer
(BioRad, Hemel Hempstead, Hertfordshire UK). The
gels were analysed using PDQuest® software version
6.2.1 (Bio Rad, Hemel Hempstead, Hertfordshire UK)
and Progenesis PG 220® V2006 software (Nonlinear
Dynamics, Newcastle upon Tyne, UK). PDQuest®
enabled the matching of identical spots in serial gels
and normalization of gels to compensate for non-
expression related variations in protein spot intensity.
The software also enabled the tracking and reporting of
all the protein patterns in the samples. By using the
comparison tool for master gels, the software facilitated
the comparison of differences between malaria infected
and control groups. Semi-quantitative analysis of spots
was performed using Progenesis PG220®.
Tryptic in-gel digestion
Eppendorf tubes and all utensils were cleaned with 50% v/v
acetonitrile/0.1% v/v TFA solution and dried. The protein
spots of interest identified on preparative gels were excized
and transferred to the Eppendorf tubes. The chopped gel
pieces were washed in 50% acetonitrile/25 mM ammonium
bicarbonate, pH 7.8, and dried in a vacuum concentrator.
Then 4-10 μl digestion buffer (10 μg/ml modified sequen-
cing grade trypsin (Promega) in 25 mM ammonium bicar-
bonate) was added to the dried gel pieces and incubated
overnight at 37°C. Resulting peptides were extracted by
addition of 4 μl water followed by 7 μl 30% acetonitirile/
0.1% TFA followed by vortexing and brief centrifugation.
The supernatant was transferred to a clean tube and
vacuum concentrated to approximately 5 μl.
Mass spectrometric identification of proteins
The concentrated sample (0.5 μl) was directly applied
onto the sample target plate with equal amounts of
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matrix (10 mg/ml a-cyano-4-hydroxycinnamic acid
(HCCA; Aldrich) in 50% acetonitrile/0.1% TFA). Mass
spectra were obtained using MALDI-MS (Shimadzu
CFR Plus, Manchester UK) in positive ion reflectron
mode at an accelerating voltage of 20 kV. The spectra
were externally calibrated using a peptide mixture
(Sigma, St Louis, MO) with masses 757.39 (Bradykinin),
1046.54 (Angiotensin II) and 2465.19 (ACTH). Spectra
obtained were used to search through the NCBI nr data-
base using the MASCOT Peptide Mass Fingerprinting
software [12] (with a tolerance of ~ +/- 0.1 D and one
missed cleavage site.
Results
Protein separation by 2-DE
Plasma samples from infected mice together with con-
trol samples were applied to 2-DE and proteins visua-
lized by silver stain for analytical gels and Coomassie
blue stain for preparative gels. Representative gel maps
for plasma from infected mice, and control mice before
and after albumin depletion were created using
PDQuest®. The gel maps are synthetic gels prepared by
analysing four replicate silver stained gels of each sam-
ple. Representative gel master gels of controls, infected,
albumin depleted control and infected had 752, 639,
921, and 610 spots respectively. Individual variation was
calculated using PDQuest and extent of correlation of
protein spots between the replicate gels was reported as
correlation coefficients. For all gel maps, correlation
between the individual gels was greater than 0.772. A
coefficient of 1.00 indicates that two gels are perfectly
similar, while a low coefficient (e.g. 0.40) indicates the
two gels are not very similar. There were protein spots
that were differentially expressed on the gel of plasma
from infected mice and some proteins were completely
absent. Removing albumin improved the quality of gels
and helped identify some additional spots of interest.
Mass spectrometry and protein identification
When stained with Coomassie between 60 and 104
spots per gel were visualized. Figure 1 shows the spots
excized from the Coomassie stained gels. These spots
were digested and prepared for MALDI analysis. It was
possible to definitively identify 51, 63, 30 and 18
Figure 1 Coomassie stained 2-D PAGE gel of plasma from mice after loading with 300 μg of sample protein. Plasma from infected mice
(A), albumin depleted plasma from infected mice (B), plasma from control mice (C) and albumin depleted plasma from control mice (D).
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proteins from the infected, control, albumin depleted
infected and albumin depleted control plasma samples
respectively. Tables 1 and 2 give a list of these uniquely
expressed proteins.
In accordance with the cut-off score recommended by
Mascot® for Rodents a protein score of 63 was consid-
ered to be significant. Removing albumin improved the
quality of gels and helped identify additional proteins.
Semi-quantitative differential analysis was done on silver
stained replicate gels using Progenesis PG 220® 2DE
software. Spots were given a match number if 3 out of 4
replicates matched perfectly. Spots matched to each
representative gel were then analysed for any changes in
intensity.
Functional cataloguing of proteins
Protein functions were identified using the Protein
Information Resource (PIR) id-mapping tool and catalo-
gued according to their gene ontology (GO) number.
The software enabled us to identify the molecular func-
tions, cellular components and biological processes of
the proteins. Figures 2 and 3 show a graphic breakdown
of identified proteins according to their GO functional
categories.
Discussion
Animal models have been developed to provide insights
into the pathogenesis and neurological complications of
malaria. Mouse models have been studied most exten-
sively to examine the function of the blood brain barrier
in malaria. Pathology of the Plasmodium berghei ANKA
mouse model used in this study develops neurological
signs, such as ataxia, hemiplegia and coma [13], clinical
features which are seen in human CM. However, in con-
trast to human CM, there is little evidence of sequestra-
tion of parasitized red blood cells (PRBCs) in the brain
[14], but rather monocytes and non-PRBCSs predomi-
nate [5]. However, recent studies have found PRBCs in
the cerebrum and cerebellum of infected mice [15].
Although the pathogenesis of the neurological compli-
cations of murine malaria appears to be more inflamma-
tory [14,15] than in human malaria, changes in protein
Table 1 List of proteins identified from the Coomassie stained gels of plasma from infected mice (Figure 2)
Spot No. Description Accession Score Matched
Peptides
Sequence
coverage(%)
1 serine (or cysteine) proteinase inhibitor, clade A, member 1a;
serine protease [Mus Musculus]
15029662 83 8 26
12, 14 similar to macrophage galactose-type C-type lectin 2 [Mus
Musculus]
38089618 78, 68 7, 6 21, 20
36 similar to spectrin alpha chain, brain (spectrin, non-erythrid
alpha chain)
38074605 71 10
42 60S ribosomal protein L35a 3914537 70 5 31
48, 50, 56, 72,
94, 95
apolipoprotein A-1 precursor - mouse 109571 137,
102,87,72,64,65
11, 9, 8, 7, 7,
6
34, 29, 27, 23,
19, 19
48, 50, 56, 67,
72, 94, 95
unamed protein product [Mus Musculus] 26345182 136, 102, 87, 76,
72, 64, 65
11, 9, 8, 8, 7,
7, 6
34, 29, 27, 28,
23, 19, 19
48, 50, 56, 94, 95 apolipoprotein A-1 [Mus Musculus] 2145135 119, 86, 72, 64, 65 10, 8, 7, 7, 6 29, 24, 22, 19, 19
48, 94 apolipoprotein A1 homolog [mus sp.] 1245804 69, 66 5, 7 53, 53
55 unamed protein product [Mus Musculus] 26341396 80 9 20
55 albumin 1; serum albumin variant [Mus Musculus] 33859506 78 9 19
55 serum albumin precursor 5915682 78 9 19
65 similar to 60S Ribsomal protein L29 (P23) [Rattus Norvegicus] 34866986 67 6 28
66 RNA binding motif protein, X chromosome [Mus Musculus] 6755296 72 8 16
66, 103 heterogenous nuclear ribonucleoprotein G [Mus Musculus] 5579009 68, 67 7, 7 20, 15
66 unamed protein product [Mus Musculus] 26339834 66 9 10
80 similar to 60S Ribsomal protein L29 (P23) [Mus Musculus] 38089196 78 7 25
80 similar to 60S Ribsomal protein L29 (P23) [Rattus Norvegicus] 34881340 71 7 30
81 unamed protein product [Mus Musculus] 26335691 69 7 25
81 heparan sulfate 6-0-sulfotransferase 1 [Mus Musculus] 20845347 64 6 28
82 similar to HRPAP20 short form [Rattus Norvegicus] 34867098 65 6 20
99 similar to Rp17a protein [Rattus Norvegicus] 34868324 86 9 16
The MALDI spectra were searched against the NCBInr database using the Mascot® search algorithm. Proteins with a significant score as defined by Mascot® were
included in the list.
Gitau et al. Malaria Journal 2011, 10:205
http://www.malariajournal.com/content/10/1/205
Page 4 of 8
Table 2 List of proteins identified from the Coomassie stained gels of plasma from control mice
Spot No. Description Accession Score Matched
Peptides
Sequence
coverage (%)
7, 23, 24, 46, 70,
71
albumin 1; serum albumin variant [Mus Musculus] 33859506 104, 104, 92, 136, 77,
76
11, 11, 11, 14,
9, 9
22, 22, 25, 26, 18,
17
22 apolipoprotein A-IV [M. musculus] 29477189 80 8 26
28 hypothetical protein XP_125606 [Mus Musculus] 20858591 65 7 22
30 lectin, galactose binding, soluble 7 [Mus Musclus] 31543120 66 6 36
35 similar to 60S ribosomal protein L7a (Sufeit locus
protein 3) PLA-X polypeptide
34869618 64 6 29
40 polyadenlate-binding protein 4 (PABP 4) [Rattus
Novegicus]
27690704 81 11 16
44 hypothetical protein XP_218509 [Rattus Norvegicus] 34855811 72 9 9
46 unamed product [Mus Musculus] 2614396 140 14 26
50, 53, 54, 55, 61,
62, 64, 65
unamed product [Mus Musculus] 26345182 64, 123, 139, 92, 153,
118, 63, 86
7, 11, 12, 9, 12,
10, 6, 8
24, 35, 38, 29, 31,
35, 18, 29
51 Non0/p54nrb homolog [Rattus Norvegicus] 2674209 71 6 23
51 stress-induced phosphoprotein 1 [Mus Musculus] 13277819 69 9 9
52 cytochrome c oxidase subunit VIIc [Mus Musculus] 6680991 70 5 36
53, 54, 55, 61, 62,
64, 65
apolipoprotein A-1 [Mus Musculus] 6753096 123, 139, 68, 153, 118,
63, 86
11, 12, 9, 12,
10, 6, 8
35, 38, 29, 31, 30,
18, 29
67, 68 major urinary protein [mice] 1839508 85, 163 7, 11 36, 42
67 similar To RIKEN Cdna 1700001e04 [Mus Musculus] 38076876 62 6 21
70 albumin [Mus Musculus] 26986064 80 7 38
71 60S Ribosoml protein L4 (L1) 3914699 78 6 39
72 transthyretin [Mus Musculus] 7305599 97 7 20
72 unamed product [Mus Musculus] 12852317 64 5 34
75 similar to hypothetical protein FLJ25333 [Mus
Musculus]
38075385 68 7 17
75 RNA binding motif protein, X chromosome [Mus
Musculus]
6755296 64 7 13
77, 78, 79 Hemoglobin beta subnit 1 [Mus Musculus] 31982300 72, 74, 93 6, 6, 7 41, 41, 61
89 heterogenous nuclear ribonucleoprotein G [Mus
Musculus]
5579009 67 7 18
Figure 2 Functional Categorization of 106 proteins identified based on gene ontology classification for Molecular Function. The Gene
Ontology (GO) numbers were derived from Protein Information Resource (PIR) -http://pir.georgetown.edu/ Batch retrieval tool. This tool
converted the GI NCBInr accession numbers to GO numbers and then used GO slim to categorize the proteins. Another 47 identified proteins
were unmatched to GO and not included in this graph.
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components of mouse plasma may provided insights
into these complications.
Of the 157 proteins identified 54 were uniquely
expressed in the plasma from infected mice. Most of the
differentially or uniquely expressed proteins in plasma
are acute phase proteins that are widely thought to indi-
cate generalized inflammation and apoptosis. Other pro-
teins identified suggest that the parasite may cause the
host to express proteins that support cell invasion and
reduce apoptosis, which would lead to better survival of
infected red blood cells.
One of the unique proteins identified was similar to
spectrin non-erythroid alpha chain brain protein (spot
36 infected gel map). This protein has recently been
shown to correlate with severity of CM in Gabonese
children [16]. Another of the proteins identified as
unique to plasma from infected mice was related to
macrophage galcotose-type C-type lectin 2 (MGL2)
(Spot 12 and 14). MGL2 is induced in diverse popula-
tions of activated macrophages, including peritoneal
macrophages during infection with the protozoan, Try-
panosoma brucei brucei or the helminth, Taenia crassi-
ceps; and alveolar macrophages in a mouse model of
allergic asthma [17]. Raes et al [17] also demonstrated
that in vitro, interleukin-4 (IL-4) and IL-13 up-regulate
MGL2 expression and that in vivo, induction of MGL2
is dependent on IL-4 receptor signaling. Moreover,
expression of MGL on human monocytes is also up-
regulated by IL-4. The study concluded that macrophage
galactose-type C-type lectins represent novel surface
markers for murine and human activated macrophages
and could be important markers of immune response in
murine malaria.
Another of the proteins identified as unique to plasma
drawn from infected mice is Baculoviral Inhibitor of
Apoptosis (IAP) repeat-containing protein 3, which is an
apoptotic suppressor. This protein interacts with tumour
necrosis factor (TNF) receptor associated factors 1 and 2
to form an heteromeric complex, which is then
recruited to the TNF receptor 2 [18]. The presence of
this protein could be protective, trying to abrograte
apoptosis caused by a massive local release of TNF in
both murine liver cells during malarial infection [19,20]
and in endothelial cells from human cerebral malaria
[21,22]. Moreover the identification of a protein similar
to hormone-regulated proliferation-associated protein 20
(HRPAP20) (spot 82 infected) suggests that in murine
malaria suppression of apoptosis plays a key role in dis-
ease progression.
Two proteins associated with mediation of anti
-inflammation, Apolipoprotein A1 (spot 42 infected
depleted) and heparan sulfate transferase 1 (spot 99
infected) were also differentially expressed strengthening
the idea that the mouse model is predominantly an
inflammatory disease.
There were 49 proteins expressed in the control gels
that were absent from malaria infected samples. These
included transthyretin (spot 72 control gel), which
sometimes acts as a retinol carrier through an associa-
tion with retinol binding protein [23]. It is normally
found at high concentrations in plasma and the fact that
it was not detected in the plasma from infected mice
Figure 3 Functional Categorization of 106 proteins identified based on gene ontology classification for Biological Process. The Gene
Ontology (GO) numbers were derived from Protein Information Resource (PIR) -http://pir.georgetown.edu/ Batch retrieval tool. This tool
converted the GI NCBInr accession numbers to GO numbers and then used GO slim to categorize the proteins. Another 47 identified proteins
were unmatched to GO and not included in this graph.
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would suggest that the levels in rodent malaria are too
low to detect or some protein modification had
occurred. Transthyretin is an acute phase protein that
decreases during an acute phase response [24]. Together
with other acute phase proteins such as transferrin and
albumin, these proteins decrease during an acute phase
response and have no apparent immune function [24].
Their main role is to transport nutrients therefore; their
reduction during infection and inflammation may lower
the concentration of specific nutrients. To support this
hypothesis it has been shown that the serum concentra-
tion of retinol, the alcohol form of vitamin A, decreases
during malarial infections. This reduction has been
characterized as a direct consequence of the inflamma-
tory response to Plasmodium infections [25,26].
Previously, several proteins have been associated with
a reduction in retinol [27-29]. The proteomic results
here suggest that transthyretin may be a useful predictor
of plasma retinol during malarial infection. This infor-
mation would be useful because the inclusion of a mea-
sure of the acute phase response would help interpret
plasma retinol concentrations during malarial infection
[25,27].
Conclusion
This study goes some way to validate the technique of
proteomics for characterising proteins differentially
expressed during disease in this case with the P. berghei
ANKA mouse malaria model. The results here suggest
that apoptosis and inflammation play a major role in
disease progression and also suggest that qualitative ana-
lysis of markers of activated macrophages could help
elucidate their role in controlling murine malaria as well
as confirming the relevance of macrophages in develop-
ing host immunity to this infection. As a whole, the
study provides a “proof of concept” on use of plasma
proteomics to help understand host response to the
malaria parasite.
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